세계의 본왁스 시장(2024-2031년)

Market Overview

The Global Bone Wax Market reached US$ 65.60 million in 2023 and is expected to reach US$ 82.00 million by 2031, growing at a CAGR of 2.8% during the forecast period 2024-2031.

Bone wax is a sterile surgical product commonly used in orthopedic, neurosurgical, and thoracic surgeries. It is composed of a mixture of beeswax and petroleum jelly, sometimes with added substances like isopropyl palmitate or lanolin. Bone wax is versatile and can be applied to various bone surfaces, including those with irregularities or small defects. Its pliable nature allows for easy molding and application, making it suitable for a wide range of surgical scenarios.

Bone wax has been a standard tool in surgical practice for many years, with a proven track record of safety and efficacy. Its importance is underscored by its widespread use across different surgical specialties and its inclusion in standard surgical protocols. Bone wax facilitates surgical precision by allowing surgeons to work in a clear and blood-free environment. This clarity enhances visibility of the surgical site, enabling surgeons to perform delicate procedures with greater accuracy and confidence.

Market Dynamics: Drivers and Restraints

Increasing prevalence of sports and recreation-related injuries

Sports and recreation-related injuries often result in fractures, particularly in weight-bearing bones such as the tibia, fibula, and femur. During fracture repair surgeries, bone wax is frequently used to control bleeding from bone surfaces, especially in cases where significant soft tissue trauma is present. The increasing incidence of fractures due to sports injuries directly correlates with the demand for bone wax.

For instance, according to article published in Johns Hopkins University 2022, estimated that, in U.S., about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year, which cause some loss of time of participation, are experienced by the participants. Almost one-third of all injuries incurred in childhood are sports-related injuries.

Additionally, according to a Weinstein Legal Team report published in March 2020, stated that, nearly 30 million children and adolescents participate in youth sports in U.S. each year. This can lead to orthopedic emergencies leading to a demand for surgeries and bone wax, thus driving the market growth. Moreover, sports injuries can result in complex trauma requiring surgical intervention, such as multiple fractures, dislocations, and bone deformities.

Market Dynamics: Restraint

Emergence of alternative hemostatic agents

The development of alternative hemostatic agents, such as synthetic sealants, hemostatic gels, and advanced hemostatic powders, may pose a challenge to the growth of the bone wax market. Surgeons may opt for these newer products over traditional bone wax, particularly in cases where specific properties like rapid hemostasis or biodegradability are desired.

Alternative hemostatic agents may offer advantages over bone wax in terms of specific properties such as rapid hemostasis, ease of use, biodegradability, or enhanced safety profiles. For instance, Baxter products like Ostene bone hemostasis material is alternative to bone wax. Additionally, newer hemostatic agents may undergo rigorous testing and clinical evaluation to obtain regulatory approval, ensuring compliance with safety and efficacy standards.

Segment Analysis

The global bone wax market is segmented based on product, material, application, end-user and region.

The absorbable bone wax from the product segment accounted for approximately 61.43% of share

There is an increasing demand for biodegradable medical products across various surgical procedures. Absorbable bone wax falls into this category, as it offers the benefits of traditional bone wax without the need for removal post-surgery. For instance, innovations in material science have led to the development of absorbable bone wax made from biocompatible materials such as polysaccharides or synthetic polymers.

These materials offer effective hemostasis while being gradually absorbed by the body, eliminating the need for a secondary surgical procedure for removal. Additionally, absorbable bone wax eliminates the risks associated with traditional bone wax, such as the potential for infection or foreign body reactions. Surgeons find it convenient to use absorbable bone wax, as it simplifies the surgical process and reduces the need for additional interventions.

While absorbable bone wax may have a higher upfront cost compared to traditional bone wax, its absorbable nature eliminates the need for a second surgical procedure for removal. This can lead to cost savings for healthcare providers and patients in the long run. Thus above factors helps to boost the segment growth.

Geographical Analysis

North America accounted for approximately 39.37% of the market share in 2023

North America, particularly the United States and Canada, boasts advanced healthcare infrastructure with a high level of access to medical facilities and surgical procedures. This infrastructure supports the adoption of advanced medical technologies, including bone wax, in surgical settings.

North America experiences a high volume of surgical procedures across various specialties, including orthopedic, neurological, and cardiovascular surgeries. For instance, according to Cleveland Clinic 2022, a sternotomy procedure is very common. It's the approach cardiac surgeon's use most often for coronary artery bypass surgery and other heart surgeries. Surgeons perform more than 700,000 sternotomies each year in the United States.

Additionally, United States, in particular, has one of the highest healthcare expenditures globally. This substantial healthcare spending creates a conducive environment for the adoption of advanced medical technologies, including bone wax, in surgical practice. Thus, above factors help to boost the region growth.

COVID-19 Impact Analysis

While elective surgeries declined, there was an increased focus on emergency and life-saving procedures, including certain cardiovascular surgeries. Bone wax continued to be essential in these emergency surgeries to control bleeding and facilitate wound closure. The pandemic underscored the importance of infection control measures in healthcare settings.

Surgeons and healthcare facilities may have become more vigilant about using sterile surgical products, including bone wax, to minimize the risk of surgical site infections and other complications. To reduce the risk of virus exposure and conserve resources, there was a trend towards performing minimally invasive procedures when possible.

While bone wax is primarily used in open surgeries like sternotomy, the overall shift towards minimally invasive techniques could have affected the demand for traditional bone wax. As vaccination efforts expanded and healthcare systems adapted to the pandemic, many regions experienced a gradual recovery in elective surgeries. This likely led to a rebound in demand for bone wax and other surgical products as surgical volumes returned to pre-pandemic levels.

Competitive Landscape

The major global players in the market include B. Braun SE, Cura Medical, Dolphin Sutures, GPC Medical Ltd, Abyrx Inc, Bentley Healthcare Pvt. Ltd., Medtronic Plc, Ethicon, Inc, Medline Industries, Inc, CORMEDICA, among others.

Why Purchase the Report?

To visualize the global bone wax market segmentation based on product, material, application, end-user and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of bone wax market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global bone wax market report would provide approximately 69 tables, 58 figures and 187 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by Material
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Market Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing prevalence of sports and recreation-related injuries
    • 4.1.1.2. Rising technological advancements of the products
• 4.2. Restraints
  • 4.2.1. Emergence of alternative hemostatic agents
  • 4.2.2. Opportunity
  • 4.2.3. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Unmet Needs
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 7.1.2. Market Attractiveness Index, By Product
• 7.2. Absorbable Bone Wax *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Non-absorbable Bone Wax

8. By Material

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 8.1.2. Market Attractiveness Index, By Material
• 8.2. Natural Bone Wax *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Synthetic Bone Wax

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Thoracic Surgery *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Orthopedic Surgery
• 9.4. Dental/Oral Surgery
• 9.5. Neurosurgery
• 9.6. Others

10. By End-User

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.1.2. Market Attractiveness Index, By End-User
• 10.2. Hospitals*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Specialty Clinics
• 10.4. Ambulatory Surgical Centers
• 10.5. Others

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1. U.S.
    • 11.2.7.2. Canada
    • 11.2.7.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. UK
    • 11.3.7.3. France
    • 11.3.7.4. Italy
    • 11.3.7.5. Spain
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia-Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan
    • 11.5.7.4. South Korea
    • 11.5.7.5. Rest of Asia-Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Market Positioning/Share Analysis
• 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

• 13.1. B. Braun SE *
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. Cura Medical
• 13.3. Dolphin Sutures
• 13.4. GPC Medical Ltd
• 13.5. Abyrx Inc
• 13.6. Bentley Healthcare Pvt. Ltd.
• 13.7. Medtronic Plc
• 13.8. Ethicon, Inc
• 13.9. Medline Industries, Inc
• 13.10. CORMEDICA (LIST NOT EXHAUSTIVE

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us